trans-Fatty acids facilitate DNA damage-induced apoptosis through the mitochondrial JNK-Sab-ROS positive feedback loop.
Adaptor Proteins, Signal Transducing
/ antagonists & inhibitors
Animals
Apoptosis
/ drug effects
Caenorhabditis elegans
Caenorhabditis elegans Proteins
/ antagonists & inhibitors
Cell Line, Tumor
DNA Fragmentation
/ drug effects
Doxorubicin
/ pharmacology
Embryo, Nonmammalian
Feedback, Physiological
Gene Expression Regulation
Guanine Nucleotide Exchange Factors
/ antagonists & inhibitors
HEK293 Cells
HeLa Cells
Human Umbilical Vein Endothelial Cells
/ cytology
Humans
JNK Mitogen-Activated Protein Kinases
/ metabolism
Linoleic Acid
/ pharmacology
Mice
Mitochondria
/ drug effects
Oleic Acids
/ pharmacology
Osteoblasts
/ cytology
Protein Tyrosine Phosphatase, Non-Receptor Type 6
/ genetics
RAW 264.7 Cells
RNA, Small Interfering
/ genetics
Reactive Oxygen Species
/ agonists
Ultraviolet Rays
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 02 2020
17 02 2020
Historique:
received:
15
07
2019
accepted:
29
01
2020
entrez:
19
2
2020
pubmed:
19
2
2020
medline:
18
11
2020
Statut:
epublish
Résumé
trans-Fatty acids (TFAs) are unsaturated fatty acids that contain one or more carbon-carbon double bonds in trans configuration. Epidemiological evidence has linked TFA consumption with various disorders, including cardiovascular diseases. However, the underlying pathological mechanisms are largely unknown. Here, we show a novel toxic mechanism of TFAs triggered by DNA damage. We found that elaidic acid (EA) and linoelaidic acid, major TFAs produced during industrial food manufacturing (so-called as industrial TFAs), but not their corresponding cis isomers, facilitated apoptosis induced by doxorubicin. Consistently, EA enhanced UV-induced embryonic lethality in C. elegans worms. The pro-apoptotic action of EA was blocked by knocking down Sab, a c-Jun N-terminal kinase (JNK)-interacting protein localizing at mitochondrial outer membrane, which mediates mutual amplification of mitochondrial reactive oxygen species (ROS) generation and JNK activation. EA enhanced doxorubicin-induced mitochondrial ROS generation and JNK activation, both of which were suppressed by Sab knockdown and pharmacological inhibition of either mitochondrial ROS generation, JNK, or Src-homology 2 domain-containing protein tyrosine phosphatase 1 (SHP1) as a Sab-associated protein. These results demonstrate that in response to DNA damage, TFAs drive the mitochondrial JNK-Sab-ROS positive feedback loop and ultimately apoptosis, which may provide insight into the common pathogenetic mechanisms of diverse TFA-related disorders.
Identifiants
pubmed: 32066809
doi: 10.1038/s41598-020-59636-6
pii: 10.1038/s41598-020-59636-6
pmc: PMC7026443
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Caenorhabditis elegans Proteins
0
Guanine Nucleotide Exchange Factors
0
Oleic Acids
0
REI-1 protein, C elegans
0
RNA, Small Interfering
0
Reactive Oxygen Species
0
SH3BP5 protein, human
0
elaidic acid
4837010H8C
Doxorubicin
80168379AG
Linoleic Acid
9KJL21T0QJ
JNK Mitogen-Activated Protein Kinases
EC 2.7.11.24
Protein Tyrosine Phosphatase, Non-Receptor Type 6
EC 3.1.3.48
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2743Références
Gebauer, S. K., Psota, T. L. & Kris-Etherton, P. M. The diversity of health effects of individual trans fatty acid isomers. Lipids 42, 787–799, https://doi.org/10.1007/s11745-007-3095-8 (2007).
doi: 10.1007/s11745-007-3095-8
pubmed: 17694343
Estadella, D. et al. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm. 2013, 137579, https://doi.org/10.1155/2013/137579 (2013).
doi: 10.1155/2013/137579
pubmed: 23509418
pmcid: 3572653
Mensink, R. P., Zock, P. L., Kester, A. D. & Katan, M. B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146–1155 (2003).
doi: 10.1093/ajcn/77.5.1146
Morris, M. C. et al. Dietary fats and the risk of incident Alzheimer disease. Arch. Neurol. 60, 194–200 (2003).
doi: 10.1001/archneur.60.2.194
Micha, R. & Mozaffarian, D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat. Rev. Endocrinol. 5, 335–344, https://doi.org/10.1038/nrendo.2009.79 (2009).
doi: 10.1038/nrendo.2009.79
pubmed: 19399016
Lopez-Garcia, E. et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 135, 562–566 (2005).
doi: 10.1093/jn/135.3.562
Iwata, N. G. et al. Trans fatty acids induce vascular inflammation and reduce vascular nitric oxide production in endothelial cells. PLoS One 6, e29600, https://doi.org/10.1371/journal.pone.0029600 (2011).
doi: 10.1371/journal.pone.0029600
pubmed: 22216328
pmcid: 3247279
Machado, R. M. et al. Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to trans fatty acids. Atherosclerosis 224, 66–74, https://doi.org/10.1016/j.atherosclerosis.2012.06.059 (2012).
doi: 10.1016/j.atherosclerosis.2012.06.059
pubmed: 22809447
Bassett, C. M. et al. Trans-fatty acids in the diet stimulate atherosclerosis. Metab. 58, 1802–1808, https://doi.org/10.1016/j.metabol.2009.06.010 (2009).
doi: 10.1016/j.metabol.2009.06.010
Siddiqui, R. A., Harvey, K. A., Ruzmetov, N., Miller, S. J. & Zaloga, G. P. n-3 fatty acids prevent whereas trans-fatty acids induce vascular inflammation and sudden cardiac death. Br. J. Nutr. 102, 1811–1819, https://doi.org/10.1017/S0007114509992030 (2009).
doi: 10.1017/S0007114509992030
pubmed: 19822033
Hirata, Y. et al. trans-Fatty acids promote proinflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway. J. Biol. Chem. 292, 8174–8185, https://doi.org/10.1074/jbc.M116.771519 (2017).
doi: 10.1074/jbc.M116.771519
pubmed: 28360100
pmcid: 5437226
Tabas, I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10, 36–46, https://doi.org/10.1038/nri2675 (2010).
doi: 10.1038/nri2675
pubmed: 19960040
Moore, K. J., Sheedy, F. J. & Fisher, E. A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709–721, https://doi.org/10.1038/nri3520 (2013).
doi: 10.1038/nri3520
pubmed: 23995626
pmcid: 4357520
Noguchi, T. et al. Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J. Biol. Chem. 283, 7657–7665, https://doi.org/10.1074/jbc.M708402200 (2008).
doi: 10.1074/jbc.M708402200
pubmed: 18211888
Roos, W. P., Thomas, A. D. & Kaina, B. DNA damage and the balance between survival and death in cancer biology. Nat. Rev. Cancer 16, 20–33, https://doi.org/10.1038/nrc.2015.2 (2016).
doi: 10.1038/nrc.2015.2
pubmed: 26678314
Roos, W. P. & Kaina, B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 12, 440–450, https://doi.org/10.1016/j.molmed.2006.07.007 (2006).
doi: 10.1016/j.molmed.2006.07.007
pubmed: 16899408
Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nat. 461, 1071–1078, https://doi.org/10.1038/nature08467 (2009).
doi: 10.1038/nature08467
Montecucco, A., Zanetta, F. & Biamonti, G. Molecular mechanisms of etoposide. EXCLI J. 14, 95–108, https://doi.org/10.17179/excli2015-561 (2015).
doi: 10.17179/excli2015-561
pubmed: 26600742
pmcid: 4652635
Roos, W. P. & Kaina, B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett. 332, 237–248, https://doi.org/10.1016/j.canlet.2012.01.007 (2013).
doi: 10.1016/j.canlet.2012.01.007
pubmed: 22261329
Biton, S. & Ashkenazi, A. NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-alpha Feedforward Signaling. Cell 145, 92–103, https://doi.org/10.1016/j.cell.2011.02.023 (2011).
doi: 10.1016/j.cell.2011.02.023
pubmed: 21458669
Yao, Y. W. et al. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway. Biochem. Bioph Res. Co. 493, 1288–1295, https://doi.org/10.1016/j.bbrc.2017.09.153 (2017).
doi: 10.1016/j.bbrc.2017.09.153
Steelman, L. S. et al. Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging 3, 192–222, https://doi.org/10.18632/aging.100296 (2011).
doi: 10.18632/aging.100296
pubmed: 21422497
pmcid: 3091517
Lambeth, J. D. Nox enzymes and the biology of reactive oxygen. Nat. Rev. Immunology 4, 181–189, https://doi.org/10.1038/nri1312 (2004).
doi: 10.1038/nri1312
pubmed: 15039755
Chambers, J. W. & LoGrasso, P. V. Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation. Journal of Biological Chemistry 286, https://doi.org/10.1074/jbc.M111.223602 (2011).
doi: 10.1074/jbc.M111.223602
Win, S. et al. New insights into the role and mechanism of c-Jun-N-terminal kinase signaling in the pathobiology of liver diseases. Hepatology 67, 2013–2024, https://doi.org/10.1002/hep.29689 (2018).
doi: 10.1002/hep.29689
pubmed: 29194686
pmcid: 5906137
Chambers, T. P., Portalatin, G. M., Paudel, I., Robbins, C. J. & Chambers, J. W. Sub-chronic administration of LY294002 sensitizes cervical cancer cells to chemotherapy by enhancing mitochondrial JNK signaling. Biochem. Bioph Res. Co. 463, 538–544, https://doi.org/10.1016/j.bbrc.2015.05.075 (2015).
doi: 10.1016/j.bbrc.2015.05.075
Win, S. et al. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity. J. Hepatol. 62, 1367–1374, https://doi.org/10.1016/j.jhep.2015.01.032 (2015).
doi: 10.1016/j.jhep.2015.01.032
pubmed: 25666017
pmcid: 4439305
Salvi, M., Brunati, A. M. & Toninello, A. Tyrosine phosphorylation in mitochondria: a new frontier in mitochondrial signaling. Free. Radic. Biol. Med. 38, 1267–1277, https://doi.org/10.1016/j.freeradbiomed.2005.02.006 (2005).
doi: 10.1016/j.freeradbiomed.2005.02.006
pubmed: 15855046
Hebert-Chatelain, E. Src kinases are important regulators of mitochondrial functions. Int. J. Biochem. Cell Biol. 45, 90–98, https://doi.org/10.1016/j.biocel.2012.08.014 (2013).
doi: 10.1016/j.biocel.2012.08.014
pubmed: 22951354
Miyazaki, T., Neff, L., Tanaka, S., Horne, W. C. & Baron, R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 160, 709–718, https://doi.org/10.1083/jcb.200209098 (2003).
doi: 10.1083/jcb.200209098
pubmed: 12615910
pmcid: 2173369
Ogura, M., Yamaki, J., Homma, M. K. & Homma, Y. Mitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components. Biochem. J. 447, 281–289, https://doi.org/10.1042/BJ20120509 (2012).
doi: 10.1042/BJ20120509
pubmed: 22823520
pmcid: 3459221
Ostman, A., Hellberg, C. & Bohmer, F. D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 6, 307–320, https://doi.org/10.1038/nrc1837 (2006).
doi: 10.1038/nrc1837
pubmed: 16557282
Yan, Y. et al. 1-Pyrroline-5-carboxylate released by prostate Cancer cell inhibit T cell proliferation and function by targeting SHP1/cytochrome c oxidoreductase/ROS Axis. J. Immunother. Cancer 6, 148, https://doi.org/10.1186/s40425-018-0466-z (2018).
doi: 10.1186/s40425-018-0466-z
pubmed: 30545412
pmcid: 6291986
Win, S., Than, T. A., Min, R. W. M., Aghajan, M. & Kaplowitz, N. c-Jun N-Terminal Kinase Mediates Mouse Liver Injury Through a Novel Sab (SH3BP5)-Dependent Pathway Leading to Inactivation of Intramitochondrial Src. Hepatology 63, 1987–2003, https://doi.org/10.1002/hep.28486 (2016).
doi: 10.1002/hep.28486
pubmed: 26845758
pmcid: 4874901
Frank, C. et al. Effective dephosphorylation of Src substrates by SHP-1. J. Biol. Chem. 279, 11375–11383, https://doi.org/10.1074/jbc.M309096200 (2004).
doi: 10.1074/jbc.M309096200
pubmed: 14699166
Chen, L. et al. Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol. Pharmacol. 70, 562–570, https://doi.org/10.1124/mol.106.025536 (2006).
doi: 10.1124/mol.106.025536
pubmed: 16717135
Craig, A. L., Moser, S. C., Bailly, A. P. & Gartner, A. Methods for studying the DNA damage response in the Caenorhabdatis elegans germ line. Methods Cell Biol. 107, 321–352, https://doi.org/10.1016/B978-0-12-394620-1.00011-4 (2012).
doi: 10.1016/B978-0-12-394620-1.00011-4
pubmed: 22226529
Lee, H. C. et al. Caenorhabditis elegans mboa-7, a member of the MBOAT family, is required for selective incorporation of polyunsaturated fatty acids into phosphatidylinositol. Mol. Biol. Cell 19, 1174–1184, https://doi.org/10.1091/mbc.e07-09-0893 (2008).
doi: 10.1091/mbc.e07-09-0893
pubmed: 18094042
pmcid: 2262980
Tabara, H., Grishok, A. & Mello, C. C. RNAi in C. elegans: soaking in the genome sequence. Sci. 282, 430–431, https://doi.org/10.1126/science.282.5388.430 (1998).
doi: 10.1126/science.282.5388.430
Kennedy, S., Wang, D. & Ruvkun, G. A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nat. 427, 645–649, https://doi.org/10.1038/nature02302 (2004).
doi: 10.1038/nature02302
Mori, K. et al. Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan. Circ. J. 79, 2017–2025, https://doi.org/10.1253/circj.CJ-14-0750 (2015).
doi: 10.1253/circj.CJ-14-0750
pubmed: 26166015
Dawczynski, C. & Lorkowski, S. Trans-fatty acids and cardiovascular risk: does origin matter? Expert. Rev. Cardiovas 14, 1001–1005, https://doi.org/10.1080/14779072.2016.1199956 (2016).
doi: 10.1080/14779072.2016.1199956
Yang, Q. H. et al. Plasma trans-Fatty Acid Concentrations Continue to Be Associated with Serum Lipid and Lipoprotein Concentrations among US Adults after Reductions in trans-Fatty Acid Intake. J. Nutr. 147, 896–907, https://doi.org/10.3945/jn.116.245597 (2017).
doi: 10.3945/jn.116.245597
pubmed: 28381527
Dorfman, S. E. et al. Metabolic implications of dietary trans-fatty acids. Obes. 17, 1200–1207, https://doi.org/10.1038/oby.2008.662 (2009).
doi: 10.1038/oby.2008.662
Hussein, O. et al. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J. Gastroenterol. 13, 361–368 (2007).
doi: 10.3748/wjg.v13.i3.361
Liu, W. H., Lin, C. C., Wang, Z. H., Mong, M. C. & Yin, M. C. Effects of protocatechuic acid on trans fat induced hepatic steatosis in mice. J. Agric. Food Chem. 58, 10247–10252, https://doi.org/10.1021/jf102379n (2010).
doi: 10.1021/jf102379n
pubmed: 20799701
Kozlov, A. V., Lancaster, J. R. Jr., Meszaros, A. T. & Weidinger, A. Mitochondria-meditated pathways of organ failure upon inflammation. Redox Biol. 13, 170–181, https://doi.org/10.1016/j.redox.2017.05.017 (2017).
doi: 10.1016/j.redox.2017.05.017
pubmed: 28578275
pmcid: 5458092
Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Sci. 275, 90–94 (1997).
doi: 10.1126/science.275.5296.90
Nishitoh, H. et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell 2, 389–395 (1998).
doi: 10.1016/S1097-2765(00)80283-X
Saitoh, M. et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596–2606, https://doi.org/10.1093/emboj/17.9.2596 (1998).
doi: 10.1093/emboj/17.9.2596
pubmed: 9564042
pmcid: 1170601
Hirata, Y. et al. TRIM48 Promotes ASK1 Activation and Cell Death through Ubiquitination-Dependent Degradation of the ASK1-Negative Regulator PRMT1. Cell Rep. 21, 2447–2457, https://doi.org/10.1016/j.celrep.2017.11.007 (2017).
doi: 10.1016/j.celrep.2017.11.007
pubmed: 29186683
Nakajima, A. et al. Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells. Oncogene 27, 76–84, https://doi.org/10.1038/sj.onc.1210624 (2008).
doi: 10.1038/sj.onc.1210624
pubmed: 17599041
Schroyer, A. L., Stimes, N. W., Saab, W. F. A. & Chadee, D. N. MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells. Oncogene 37, 1031–1040, https://doi.org/10.1038/onc.2017.396 (2018).
doi: 10.1038/onc.2017.396
pubmed: 29084209
Kim, H. S., Ullevig, S. L., Zamora, D., Lee, C. F. & Asmis, R. Redox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment. P Natl Acad. Sci. USA 109, E2803–E2812, https://doi.org/10.1073/pnas.1212596109 (2012).
doi: 10.1073/pnas.1212596109
Xu, C. et al. Rapamycin ameliorates cadmium-induced activation of MAPK pathway and neuronal apoptosis by preventing mitochondrial ROS inactivation of PP2A. Neuropharmacol. 105, 270–284, https://doi.org/10.1016/j.neuropharm.2016.01.030 (2016).
doi: 10.1016/j.neuropharm.2016.01.030
Koh, E. M. et al. Ferulate, an Active Component of Wheat Germ, Ameliorates Oxidative Stress-Induced PTK/PTP Imbalance and PP2A Inactivation. Tox Res. 34, 333–341, https://doi.org/10.5487/Tr.2018.34.4.333 (2018).
doi: 10.5487/Tr.2018.34.4.333
Picco, V., Pages, G. & Linking, J. N. K. Activity to the DNA Damage Response. Genes. Cancer 4, 360–368, https://doi.org/10.1177/1947601913486347 (2013).
doi: 10.1177/1947601913486347
pubmed: 24349633
pmcid: 3863338
Fritz, G. & Henninger, C. Rho GTPases: Novel Players in the Regulation of the DNA Damage Response? Biomolecules 5, 2417–2434, https://doi.org/10.3390/biom5042417 (2015).
doi: 10.3390/biom5042417
pubmed: 26437439
pmcid: 4693241
Mercer, J., Mahmoudi, M. & Bennett, M. DNA damage, p53, apoptosis and vascular disease. Mutat. Res. 621, 75–86, https://doi.org/10.1016/j.mrfmmm.2007.02.011 (2007).
doi: 10.1016/j.mrfmmm.2007.02.011
pubmed: 17382357
Shah, N. R. & Mahmoudi, M. The role of DNA damage and repair in atherosclerosis: A review. J. Mol. Cell Cardiol. 86, 147–157, https://doi.org/10.1016/j.yjmcc.2015.07.005 (2015).
doi: 10.1016/j.yjmcc.2015.07.005
pubmed: 26211712
Madabhushi, R., Pan, L. & Tsai, L. H. DNA damage and its links to neurodegeneration. Neuron 83, 266–282, https://doi.org/10.1016/j.neuron.2014.06.034 (2014).
doi: 10.1016/j.neuron.2014.06.034
pubmed: 25033177
pmcid: 5564444
Amini, N. et al. Requirement of JNK1 for endothelial cell injury in atherogenesis. Atherosclerosis 235, 613–618, https://doi.org/10.1016/j.atherosclerosis.2014.05.950 (2014).
doi: 10.1016/j.atherosclerosis.2014.05.950
pubmed: 24956536
pmcid: 4104040
Kondo, K. et al. Trans-fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll-like receptors. Mol. Nutr. Food Res. 59, 729–740, https://doi.org/10.1002/mnfr.201400537 (2015).
doi: 10.1002/mnfr.201400537
pubmed: 25546502
Paudel, I., Hernandez, S. M., Portalatin, G. M., Chambers, T. P. & Chambers, J. W. Sab concentrations indicate chemotherapeutic susceptibility in ovarian cancer cell lines. Biochem. J. 475, 3471–3492, https://doi.org/10.1042/BCJ20180603 (2018).
doi: 10.1042/BCJ20180603
pubmed: 30322886
Win, S., Than, T. A., Han, D., Petrovic, L. M. & Kaplowitz, N. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice. J. Biol. Chem. 286, 35071–35078, https://doi.org/10.1074/jbc.M111.276089 (2011).
doi: 10.1074/jbc.M111.276089
pubmed: 21844199
pmcid: 3186406
Win, S., Than, T. A., Fernandez-Checa, J. C. & Kaplowitz, N. JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death Dis. 5, e989, https://doi.org/10.1038/cddis.2013.522 (2014).
doi: 10.1038/cddis.2013.522
pubmed: 24407242
pmcid: 4040675
Chambers, J. W., Howard, S. & LoGrasso, P. V. Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo. J. Biol. Chem. 288, 1079–1087, https://doi.org/10.1074/jbc.M112.421354 (2013).
doi: 10.1074/jbc.M112.421354
pubmed: 23184940
Chambers, J. W., Pachori, A., Howard, S., Iqbal, S. & LoGrasso, P. V. Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats. J. Biol. Chem. 288, 4000–4011, https://doi.org/10.1074/jbc.M112.406777 (2013).
doi: 10.1074/jbc.M112.406777
pubmed: 23258542
Chambers, T. P., Santiesteban, L., Gomez, D. & Chambers, J. W. Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity. Toxicol. 382, 24–35, https://doi.org/10.1016/j.tox.2017.03.006 (2017).
doi: 10.1016/j.tox.2017.03.006
Vallerie, S. N. & Hotamisligil, G. S. The role of JNK proteins in metabolism. Sci. Transl. Med. 2, 60rv65, https://doi.org/10.1126/scitranslmed.3001007 (2010).
doi: 10.1126/scitranslmed.3001007
Mehan, S., Meena, H., Sharma, D. & Sankhla, R. JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci. 43, 376–390, https://doi.org/10.1007/s12031-010-9454-6 (2011).
doi: 10.1007/s12031-010-9454-6
pubmed: 20878262
Pal, M., Febbraio, M. A. & Lancaster, G. I. The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance. J. Physiol. 594, 267–279, https://doi.org/10.1113/JP271457 (2016).
doi: 10.1113/JP271457
pubmed: 26608096
Chambers, J. W., Cherry, L., Laughlin, J. D., Figuera-Losada, M. & Lograsso, P. V. Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1). ACS Chem. Biol. 6, 808–818, https://doi.org/10.1021/cb200062a (2011).
doi: 10.1021/cb200062a
pubmed: 21563797
pmcid: 3158843
Win, S., Than, T. A. & Kaplowitz, N. The Regulation of JNK Signaling Pathways in Cell Death through the Interplay with Mitochondrial SAB and Upstream Post-Translational Effects. Int J Mol Sci 19, https://doi.org/10.3390/ijms19113657 (2018).
doi: 10.3390/ijms19113657
Cousin, S. P. et al. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1. Endocrinol. 142, 229–240, https://doi.org/10.1210/endo.142.1.7863 (2001).
doi: 10.1210/endo.142.1.7863
Noguchi, T. et al. Nuclear-accumulated SQSTM1/p62-based ALIS act as microdomains sensing cellular stresses and triggering oxidative stress-induced parthanatos. Cell Death Dis. 9, 1193, https://doi.org/10.1038/s41419-018-1245-y (2018).
doi: 10.1038/s41419-018-1245-y
pubmed: 30546061
pmcid: 6294141
Mali, P. et al. RNA-guided human genome engineering via Cas9. Sci. 339, 823–826, https://doi.org/10.1126/science.1232033 (2013).
doi: 10.1126/science.1232033
Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Sci. 339, 819–823, https://doi.org/10.1126/science.1231143 (2013).
doi: 10.1126/science.1231143
Naito, Y., Hino, K., Bono, H. & Ui-Tei, K. CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites. Bioinforma. 31, 1120–1123, https://doi.org/10.1093/bioinformatics/btu743 (2015).
doi: 10.1093/bioinformatics/btu743
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784, https://doi.org/10.1038/nmeth.3047 (2014).
doi: 10.1038/nmeth.3047
pubmed: 25075903
pmcid: 25075903
Brenner, S. The genetics of Caenorhabditis elegans. Genet. 77, 71–94 (1974).
Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G. & Ahringer, J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2, RESEARCH0002, https://doi.org/10.1186/gb-2000-2-1-research0002 (2001).
doi: 10.1186/gb-2000-2-1-research0002
pubmed: 11178279
Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nat. 421, 231–237, https://doi.org/10.1038/nature01278 (2003).
doi: 10.1038/nature01278
Rual, J. F. et al. Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res. 14, 2162–2168, https://doi.org/10.1101/gr.2505604 (2004).
doi: 10.1101/gr.2505604
pubmed: 15489339
pmcid: 528933